Center for Drug Evaluation and Research growing crisis around HIV testing and treatment and an inter-agency dispute between officials from the former Bureau of Drugs and officials from the former Bureau of Biologics over whether to approve Genentech's Activase (tissue plasminogen activator) led to the split. In its original form, CDER was composed of six offices: Management, Compliance, Drug Standards, Drug Evaluation I, Drug Evaluation II, Epidemiology and Biostatistics, and Research Resources. The Division of Antiviral Products was added in 1989 under Drug Evaluation II due to the large amount of drugs proposed for treating AIDS. The Office of Generic Drugs was also formed. In 2002,
Medical nutrition therapy Services' Food and Drug Administration, {within their 'Medical Foods Guidance Documents & Regulatory Information' guide in section 5(b) of the Orphan Drug Act (21 U.S.C. 30ee (b) (3))}; as “a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation,” The following advantages come with medical nutrition: The following are some disadvantages of medical nutrition: Medical nutrition therapy Medical nutrition therapy (MNT) is a therapeutic